Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 42Y93 | — |
Kinrix vaccine was given to a 23-month-old patient; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old male patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. On 07-AUG-2025, the patient received the 1st dose of Kinrix. On 07-AUG-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix vaccine was given to a 23-month-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-AUG-2025 The medical clinic supervisor reported that a Kinrix vaccine was given to a 23-month-old patient, which led to inappropriate age at vaccine administration. The reporter asked does it count and was it a valid dose. The Vaccine Administration Facility is the same as Primary Reporter